In the crosshairs of the latest controversy on whether a drug is spurious or “not of standard quality” is the Indian patient. The pharma industry suffered a body blow recently after government agencies pulled up over 50 popular medicine brands. How do patients trust their medicines?
Related Posts
How rising awareness about infertility is making IVF a USD4.6 billion opportunity
Infertility, once shrouded in cultural taboos and superstition, has emerged as a critical health issue worldwide. In India, the narrative…
Why leading doctors, scientists pin hope on green jackfruit to fight fatty liver and cancer
Visualisation by Sadhana Saxena via Ai Synopsis A recent animal study has proven green jackfruit flour’s potency in treating fatty…
We do a few things, but those few things must be the best in the world: Novo Nordisk’s top exec
Maziar Mike Doustdar, executive VP, Novo Nordisk; image credit: Company Synopsis Novo Nordisk, the most valuable pharmaceutical company in the…
